Drug Shortage Report for PRIVA-GABAPENTIN

Last updated on 2019-02-06 History
Report ID 57134
Drug Identification Number 02450097
Brand name PRIVA-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name PHARMAPAR INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-07-31
Actual start date 2018-07-31
Estimated end date 2019-02-01
Actual end date 2019-02-05
Shortage status Resolved
Updated date 2019-02-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1565 BOUL LIONEL-BOULET
VARENNES, QUEBEC
CANADA J3X 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-31 English Compare
v2 2018-07-31 English Compare
v3 2018-07-31 French Compare
v4 2018-08-01 English Compare
v5 2018-10-17 English Compare
v6 2018-10-17 French Compare
v7 2018-11-28 English Compare
v8 2018-11-28 French Compare
v9 2018-12-19 English Compare
v10 2018-12-19 French Compare
v11 2019-01-10 English Compare
v12 2019-01-10 French Compare
v13 2019-01-14 English Compare
v14 2019-01-14 French Compare
v15 2019-01-18 English Compare
v16 2019-01-18 French Compare
v17 2019-02-06 English Compare
v18 2019-02-06 French Compare

Showing 1 to 18 of 18